Advanced Practice Providers Oncology Summit.
Oncology 102 Virtual Conference
October 9th - 11th 2025
A Hematology and Oncology Primer for Advanced Practice Providers

To assist APPs in their new careers in oncology-based practices, Horizon CME, in partnership
with APAO, has developed “Oncology 102: An In-Depth Hematology and Oncology Review for
Advanced Practice Providers.” In this two-and-a-half-day virtual program, clinicians will gain a
greater understanding of cancer treatment, cancer therapies, side effects, supportive care
strategies, palliative care, and more. Expert faculty will provide a detailed review of treatment
strategies for hematologic disorders and solid malignancies. Participation in the program will
allow APPs to build upon the foundational knowledge acquired in Oncology 101 and provide
APPs with a deeper understanding of the cancer treatment strategies they need to support and
care for cancer patients as part of the multidisciplinary oncology care team.
This program is appropriate for nurse practitioners, physician assistants, nurses, and
pharmacists in hematology/oncology seeking an in-depth review of cancer treatment strategies
and therapies.
*Students - Fellows
Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.
If you would like to attend as a Student, please contact info@horizoncme.com for further information.
**Industry Employee - $400+
**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).
Please note: times are subject to change. Please check the syllabus for the most current version of the program. Commercial Support: This activity is supported in part by independent medical education grants from Merck Sharp & Dohme LLC and Regeneron Pharmaceuticals, Inc.
All Times Listed are for the Eastern Standard Time Zone
Thursday, October 9, 2025 | |
11:00am | Welcome, Introductions, & CE Housekeeping |
11:15am | (01) TBA » TBA |
11:45am | (02) TBA » Alicia M. Rigby, MSN, RN, APRN, AOCNP – Nurse Practitioner University of California, Davis |
12:45pm | Stump the Faculty – Panel Q&A Discussion |
1:00pm | Break |
1:15pm | (03) TBA » Tanya Uritsky, PharmD, BCPP – Opioid Stewardship Coordinator University of Pennsylvania |
2:15pm | (04) TBA » Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP – Clinical Oncology Pharmacist University of Illinois College of Pharmacy |
3:15pm | Stump the Faculty – Panel Q&A Discussion |
3:30pm | Break |
3:45pm | (05) TBA » TBA |
4:15pm | (06) TBA » Jennifer Brownell, PharmD – Ambulatory pharmacy manager Clearview Cancer Institute |
4:45pm | (06) TBA » Bridgett Harr, CNP – Nurse Practitioner Cleveland Clinic |
5:45pm | Stump the Faculty – Panel Q&A Discussion |
6:00pm | Adjourn |
Friday, October 10, 2025 | |
7:55am | Welcome, Introductions, & CE Housekeeping |
8:00am | (08) TBA » TBA |
8:30am | Stump the Faculty – Panel Q&A Discussion |
8:45am | (09) TBA » Kayla Freeman, DNP, APRN, FNP-C – Breast Oncology Nurse Practitioner Emory Winship Cancer Institute |
9:45am | (10) TBA » Sujata Kane, MS, RD, PA-C – Physician Assistant Winship Cancer Institute, Emory University |
3:50pm | (11) TBA » Justin Baker, MD – Chief, Division of Quality of Life and Palliative Care Stanford School of Medicine |
10:15am | Stump the Faculty – Panel Q&A Discussion |
10:30am | Break |
10:45am | (11) TBA » Beth Sandy, MSN, CRNP – Nurse Practitioner, Thoracic Medical Oncology Abramson Cancer Center, University of Pennsylvania |
11:45am | (12) TBA » TBA |
12:45pm | Stump the Faculty – Panel Q&A Discussion |
1:00pm | Lunch Break |
1:30pm | (13) TBA » Kristin M. Daly, MSN, ANP-BC, AOCNP – Medical Oncology Nurse Practitioner Siteman Cancer Center Washington University, St. Louis School of Medicine |
2:30pm | (14) TBA » Sujata Kane, MS, RD, PA-C – Physician Assistant Winship Cancer Institute, Emory University |
3:30pm | Stump the Faculty – Panel Q&A Discussion |
3:45pm | Break |
4:00pm | (15) TBA » Kathryn L. Green, CRNP, MSN – Nurse Practitioner, Medical Oncology Abramson Cancer Center, University of Pennsylvania » Taylor Aldridge, MMS, PA-C – Physician Assistant, Division of Surgical Oncology, Hepatobiliary and Pancreatic Surgery Stanford University |
5:00pm | (16) TBA » Rachel Frankenthal, PA-C – Gynecologic Oncology Physician Assistant UCLA Health |
5:30pm | Stump the Faculty – Panel Q&A Discussion |
5:45pm | Adjourn |
Saturday, October 11, 2025 | |
7:55am | Welcome, Introductions, & CE Housekeeping |
8:00am | (17) TBA » Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN – Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic » Donna Catamero, ANP-BC, OCN, CCRC – Associate Director of Myeloma Research Icahn School of Medicine at Mount Sinai Hospital |
9:00am | Stump the Faculty – Panel Q&A Discussion |
9:15am | (18) TBA » Lisa Nodzon PhD, APRN, AOCNP – Advanced Registered Nurse Practitioner Moffitt Cancer Center |
9:45am | (19) TBA » Alex Palmer |
10:15am | Stump the Faculty – Panel Q&A Discussion |
10:30am | Break |
10:50am | (20) TBA » Jennie M. Goble, PA-C – Physician Assistant Mayo Clinic |
11:50am | Lunch Break |
12:20pm | (21) TBA » TBA |
1:35pm | (22) TBA » Amitkumar Mehta, MD – Associate Professor of Medicine, Director of Lymphoma, CAR-T Cell Therapy Program University of Alabama |
2:35pm | (23) TBA » Anne Katz, PhD, RN, FAAN – AASECT-Certified Sexuality Counselor Cancer Care Manitoba |
3:35pm | Stump the Faculty – Panel Q&A Discussion |
3:50pm | Closing Comments |
Available Credit
- 21.75 AMA PRA Category 1 Credit™Horizon CME designates this Live activity for a maximum of 21.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 21.75 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 21.75 credit.
- 4.75 PharmacologyThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 4.75 credit.
Learning Objectives
Learning Objectives
- Outline strategies for the treatment of common solid and hematologic malignancies
- Summarize the role of genetics and molecular testing in cancer care
- Implement palliative care and pain management strategies for patients with cancer
- Discuss strategies for the administration and management of chemotherapy
- Identify and appropriately manage immune-related adverse events
- Recognize and treat the adverse effects associated with radiation oncology
Intended Learners
This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.